NCT06380192 · ClinicalTrials.gov record · last posted 2025-06-29
Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data
Study acronym: DEE-RETRO
StatusRecruiting
PhaseNot specified
Started2024-10-31
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Developmental and Epileptic Encephalopathy (DEE) are a heterogeneous group of neurodevelopmental disorders linked to both epilepsy and its underlying etiology, independently of epileptiform activity.
The creation of a database with retrospective follow-up of a large number of patients on a national scale will enable better knowledge of specific biomarkers, and thus a better classification and understanding of the natural evolution of DEE according to their etiology. This will enable better, more personalized therapeutic management of patients, depending on etiology and the presence or absence of these biomarkers. The investigators will also be able to draw up management recommendations, which are currently non-existent.
Amendment record
3 amendments on the ClinicalTrials.gov record
This ClinicalTrials.gov record has been amended 3 times since 2024-04-18; most recent amendment 2025-06-25. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history.
See every version on ClinicalTrials.gov ↗
2025-01-13
Status change Not Yet Recruiting→Recruitingv1
| NCT Number |
NCT06380192 |
| Lead Sponsor |
Imagine Institute
|
| Conditions |
Developmental and Epileptic Encephalopathy |
| Enrollment |
400 participants |
| Start Date |
2024-10-31 |
| Primary Completion |
2026-12-31 (estimated) |
| Study Completion |
2026-12-31 (estimated) |
| Updated on ClinicalTrials.gov |
2025-06-29 |